SCHEMBL30444577

SCHEMBL30444577

Cn1ncc2ccc(OB(O)O)cc21

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.42
ERCC1 P07992 1/20 0.41
ERCC4 Q92889 1/20 0.41
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
PDE1C Q14123 1/20 0.40
HAO1 Q9UJM8 2/20 0.40
PRMT5 O14744 4/20 0.39
SCN9A Q15858 1/20 0.39
ESRRG P62508 2/20 0.38
HDAC4 P56524 2/20 0.37
WDR77 Q9BQA1 1/20 0.36
VNN1 O95497 1/20 0.36
CCNC P24863 1/20 0.36
CDK8 P49336 1/20 0.36
KMO O15229 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30818113 0.87 PDE1C (0.40) NOTUMPDE1CHAO1CCNCCDK8
SCHEMBL926260 0.87 PDE1C (0.40) NOTUMPDE1CHAO1CCNCCDK8
SCHEMBL13113212 0.80 HTR2A (0.59) NOTUMERCC1ERCC4HTR2AHTR2C
SCHEMBL17473919 0.77 HTR2A (0.42) NOTUMERCC1ERCC4HTR2AHTR2C
SCHEMBL9707251 0.76 HAO1 (0.46) NOTUMERCC1ERCC4HTR2AHTR2C
SCHEMBL19475346 0.75 PDE1C (0.47) NOTUMERCC1ERCC4HTR2AHTR2C
SCHEMBL30864172 0.75 CYP2A6 (0.46) HTR2AHTR2C
SCHEMBL876657 0.75 NOTUM (0.44) NOTUMERCC1ERCC4HTR2AHTR2C
SCHEMBL29953317 0.75 NOTUM (0.44) NOTUMERCC1ERCC4HTR2AHTR2C
SCHEMBL30896342 0.74 HAO1 (0.45) HTR2AHTR2CHTR2BHAO1PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117529476-A Preparation of substituted 1, 2-diamino heterocyclic derivatives and their use as medicaments 亚飞络思制药公司 2024-02-06 CN disclosed
CN-116456985-A Pyrimidine and pyridine derivatives as HPK1 modulators and methods of use thereof 深圳市原力生命科学有限公司 2023-07-18 CN disclosed